TG Therapeutics Inc
TGTX
$57.37-0.26%
Delayed · as of Sep 25, 2026, 1:45 PM ET
Mkt cap
$7.88B
EV/Sales
13.1
P/E ratio
N/A
FY2025 Revenue
$616.29M
EPS (TTM)
$2.74
Gross Margin (FY2025)
83.66%
Profit Margin (FY2025)
72.56%
Beta
N/A
Div yield
N/A
Sector
Healthcare
TG Therapeutics Inc (TGTX) is a biotechnology company listed on NASDAQ.
Latest reported TGTX revenue for 2025-12-31 was $616.3M. Net income was $447.2M. Revenue was up 87.3% from 2024-12-31 to 2025-12-31. TGTX currently screens at market cap $7.88B.
Use this TGTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full TGTX income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
TG Therapeutics Inc (TGTX) is a biotechnology company in the Healthcare sector.
Latest cached TG Therapeutics Inc (TGTX) revenue for Dec 31, 2025 was $616.3M. Net income was $447.2M. Statements: https://lician.com/financials/tgtx
TG Therapeutics Inc (TGTX) market capitalization is $7.88B on the latest cached snapshot.
TG Therapeutics Inc (TGTX) cached previous close $57.52; day range $56.61 – $58.69; volume 386,808. Session quote: https://lician.com/quote/tgtx
TG Therapeutics Inc (TGTX) latest cached earnings event is "TGTX earnings" on Aug 3, 2026. Earnings calendar: https://lician.com/earnings
The latest cached TGTX filing is 8-K · Aug 3, 2026. Filings: https://lician.com/sec/tgtx